Decro Pharma Private Limited - Company Profile

It is a chemicals and materials private limited company based in Indrad, Gujarat, India, established in 2020.
2020 Indrad, Gujarat, India Active
Last Updated:
Access Report
About Decro Pharma Private Limited

Decro Pharma Private Limited, a active private limited company, was established on 21 October 2020 in Indrad, Gujarat, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24210GJ2020PTC117562. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹6.50 Cr.

It upholds a compliant status. Its leadership includes Sangitaben Rakeshkumar Patel (Director), Rakesh Ambalal Patel (Director), Arvindbhai Patel (Director). Past directors included Sangitaben Rakeshkumar Patel, Arvindbhai Patel. It holds ₹38.80 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at New Survey No.- 466, Plot No 7, Umiya Industrial Estate, Ta. Kadi,, Indrad, Gujarat, 382715.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24210GJ2020PTC117562

  • Registration Number

    117562

  • Incorporation Date

    21 October 2020

  • Authorized Capital

    ₹6.50 Cr

  • Paid-Up Capital

    ₹6.50 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.50 Cr
  • Paid Up Capital ₹ 6.50 Cr
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 38.80 Cr
  • Revenue Growth **** 3390.18%
  • Profit Growth **** 4628.00%
  • Ebitda **** -955.15%
  • Net Worth 53598.64%
  • Total Assets **** 225.87%
Company report

Decro Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Decro Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Decro Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sangitaben Rakeshkumar Patel Director 08 May 2021 Current
Rakesh Ambalal Patel Director 21 Oct 2020 Current
Arvindbhai Patel Director 08 May 2021 Current
Bhikan Nimba Patil Director 21 Oct 2020 Current
Narendra Rajdev Pandey Director 21 Oct 2020 Current
Hareshbhai Kalabhai Patel Director 21 Oct 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Decro Pharma.

Decro Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 3390.18% increase. The company also saw a substantial improvement in profitability, with a 4628% increase in profit. The company's net worth Soared by an impressive increase of 53598.64%.

Decro Pharma revenue growth over time
Decro Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3390.18%
*******
*******
*******
*******
Revenue from Operations
*******
 2316.00%
*******
*******
*******
*******
Total Assets
*******
 225.87%
*******
*******
*******
*******
Profit or Loss
*******
 4628.00%
*******
*******
*******
*******
Net Worth
*******
 53598.64%
*******
*******
*******
*******
EBITDA
*******
 -955.15%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Decro Pharma?

In 2023, Decro Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹388,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 38.80 Cr
Latest Charge Details
Date Lender Amount Status
30 Mar 2022 State Bank Of India ₹19.40 Cr Open
30 Mar 2022 State Bank Of India ₹19.40 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Decro Pharma?

Decro Pharma has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Decro Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decro Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Decro Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Decro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Decro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.

  • Charges

    The activity A charge with State Bank Of India of Rs. 19.40 Cr registered on 30 Mar 2022 with Charge ID 100567876 was modified on 26 Apr 2024. was completed.

  • Charges

    The activity A charge with State Bank Of India of Rs. 19.40 Cr registered on 30 Mar 2022 with Charge ID 100568091 was modified on 26 Apr 2024. was completed.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 19.40 Cr with Charge ID 100567876 was registered on 30 Mar 2022. was completed.

  • Charges

    A charge with State Bank Of India amounted to Rs. 19.40 Cr with Charge ID 100568091 was registered on 30 Mar 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Decro Pharma Private Limited?

The CIN of Decro Pharma Private Limited is U24210GJ2020PTC117562.

Where is Decro Pharma Private Limited headquartered?

Decro Pharma Private Limited is headquartered at New Survey No.- 466, Plot No 7, Umiya Industrial Estate, Ta. Kadi,, Indrad, Gujarat, 382715.

When was Decro Pharma Private Limited incorporated?

Decro Pharma Private Limited was incorporated on 21 October 2020.

Who are the current directors of Decro Pharma Private Limited?

The current directors of Decro Pharma Private Limited are

What is the primary industry of Decro Pharma Private Limited?

The primary industry of Decro Pharma Private Limited is Manufacturing.

Is Decro Pharma Private Limited a listed company?

Decro Pharma Private Limited is unlisted.

What is the capital structure of Decro Pharma Private Limited?

The authorized capital of Decro Pharma Private Limited is ₹6.50 Cr, and the paid-up capital is ₹6.50 Cr.

What is the compliance status of Decro Pharma Private Limited?

The compliance status of Decro Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available